National Storage Mechanism | Additional information

6 November 2025

Spectris plc (the "Company")

Listing Rule 6.4.9(2) Disclosure

In accordance with Listing Rule 6.4.9(2), Spectris plc confirms that it has been informed on 6 November 2025 by Dr. Ravi Gopinath, Independent Non-Executive Director of the Company, that he has been appointed as an independent director of Neuland Laboratories, a company listed on the National Stock Exchange of India and the Bombay Stock Exchange.

Name of contact and telephone number for queries:

Harriet Huband

Head of Secretariat

+44 75541 97627

LEI Number: 213800Z4CO2CZO3M3T10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END